common challenges glp-1 users Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Starting GLP-1s: What Users Wish

It reduces HbA1c by approximately 1.5-2.0 percentage points in diabetic populations, which is clinically excellent

This patient cohort was matched with patients with T2DM who did not receive GLP-1 RAs according to age, demographics, comorbidities, and medication by using 1:1 propensity matching

Quite Nice is a fortified superfood oatmeal made with plant protein and prebiotic fiber that feeds the good bacteria in your gut

The article described how the administration of an anti-mouse GIPR antibody (muGIPR-Ab) prevented weight gain in diet-induced obesity (DIO) mice, improved various metabolic parameters, and was associated with a reduction in food intake and the resting respiratory exchange ratio

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy

Then an endocrinologist asked if he'd like to try one of the new class of glucagon-like peptide-1, or GLP-1, drugs that include Wegovy and Mounjaro